Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor

Pharmacogenetics and Genomics

Volumn 21, Issue 7, 2011, Pages 436-439

  García Martín, Elena ^a   Martínez, Carmen ^a   Alonso Navarro, Hortensia ^b,c   Benito León, Julián ^d,e   Lorenzo Betancor, Oswaldo ^f,g   Pastor, Pau ^e,f,g   Puertas, Inmaculada ^b   Rubio, Lluisa ^b   López Alburquerque, Tomás ^h   Agúndez, José A G ^a   Jiménez Jiménez, Félix Javier ^b,f,i  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c Hospital Universitario del Sureste de Madrid   (Spain)

^d HOSPITAL DE MÓSTOLES   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^f Center for Applied Medical Research   (Spain)

^g UNIVERSITY OF NAVARRA   (Spain)

^h HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

ⁱ Hospital Del Sureste   (Spain)

Author keywords

essential tremor; genetics polymorphisms; risk factors; aminobutyrate A receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; ALANINE; ISOLEUCINE; LEUCINE; METHIONINE; SERINE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESSENTIAL TREMOR; FEMALE; GABRA4 GENE; GABRE GENE; GABRQ GENE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79959792600     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328345bec0     Document Type: Article

References (11)

1. Alonso-Navarro H, Benito-León J, Vázquez-Rodríguez A, Rubio LL, Jimé nez-Jimé nez FJ. Essential tremor. In: Jimé nez-Jiménez FJ, Luquin MR, Molina JA, Linazasoro G, editors. Textbook of movement disorders. 2nd ed. (ISBN 978-84-85424-76-4). Barcelona: Viguera Editores S.L; 2008. pp. 833-886.
2. Kralic JE, Criswell HE, Osterman JL, O'Buckley TK,Wilkie ME, Matthews DB, et al. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest 2005; 115:774-779. (Pubitemid 40322254)
3. Mally J, Baranyi M, Vizi ES. Change in the concentration of amino acids in CSF and serum of patients with essential tremor. J Neural Transm (Gen Sect) 1996; 103:555-560. (Pubitemid 26383642)
4. Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice. Eur J Pharmacol 2009; 616:73-80.
5. Olsen RW, SieghartW. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 2008; 60:243-260.
6. Deuschl G, Bain P, Brin M; Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on Tremor. Mov Disord 1998; .13. (Suppl 3):2-23. (Pubitemid 28517753)
7. García-Martín E, Martínez C, Alonso-Navarro H, Benito-León J, Lorenzo-Betancor O, Pastor P, et al. Gamma-aminobutyric acid (GABA) receptors rho (GABRR) polymorphisms and risk for essential tremor. J Neurol 258:203-211.
8. Benito-León J, Bemejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of Central Spain. Mov Disord 2003; 18:389-394. (Pubitemid 36527279)
9. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989. (Pubitemid 32289743)
10. Deng H, Xie WJ, Le WD, Huang MS, Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett 2006; 401:16-19.
11. Thier S, Kuhlenbäumer G, Lorenz D, Nothnagel M, Nebel A, Chirstensen K, et al. GABAA receptor and GABA transporter polymorphisms and risk for essential tremor. Eur J Neurol 2011; 18. [Epub ahead of print]. DOI: 10.1111/j.1468-1331.2010.03308.x